Pseudomembranous colitis is an inflammatory condition of the colon where yellowish-white plaques form on the inner lining, creating a characteristic “pseudomembrane.” It is almost always caused by an overgrowth of the bacterium Clostridioides difficile (C. diff), typically after antibiotic use disrupts the normal balance of gut bacteria. With an overall death rate of about 12% across all cases, it is a serious condition that requires prompt treatment.
How It Develops
Your colon is home to trillions of bacteria that keep each other in check. When antibiotics kill off large portions of these protective bacteria, C. diff can multiply rapidly and take over. As it grows, C. diff releases two powerful toxins that attack the cells lining your colon.
These toxins enter colon cells and disrupt their internal structure, essentially causing the cells to lose their shape and die. They also break down the tight seals between neighboring cells, which allows immune cells called neutrophils to flood into the tissue. This triggers a strong inflammatory response. The combination of dead cells, immune cells, and inflammatory debris accumulates on the colon’s surface, forming the raised yellow-white patches that define pseudomembranous colitis. As the patches grow and merge, they create a continuous membrane-like coating visible during a colonoscopy.
Which Antibiotics Carry the Highest Risk
Nearly any antibiotic can set the stage for C. diff overgrowth, but broad-spectrum antibiotics (those that target many types of bacteria at once) pose the greatest risk. The most commonly implicated classes include:
- Clindamycin: historically one of the strongest triggers
- Penicillins: particularly ampicillin and amoxicillin
- Cephalosporins: a widely prescribed class used for many common infections
- Fluoroquinolones: such as ciprofloxacin and levofloxacin
The risk increases with longer courses of antibiotics and with use of multiple antibiotics at the same time. Parenteral aminoglycosides, sulfonamides, and vancomycin are among the few antibiotics that rarely trigger the condition.
Other Risk Factors
Antibiotics are the primary trigger, but several factors raise your overall vulnerability. Age is one of the biggest: C. diff infection rates climb sharply in people over 65. Hospitalization and stays in long-term care facilities dramatically increase exposure. Long-term care facilities report roughly 44 cases per 10,000 patient-days, far higher than most other settings. Hospital intensive care units see about 5 cases per 1,000 admissions.
A weakened immune system, whether from chemotherapy, organ transplant medications, or chronic illness, also raises risk. So does the use of proton pump inhibitors (stomach acid reducers), since stomach acid normally helps keep C. diff in check before it reaches the colon.
Symptoms to Recognize
The hallmark symptom is watery diarrhea, often occurring three or more times a day, that begins during or shortly after a course of antibiotics. In mild cases this may be the only symptom, but more severe infections produce cramping abdominal pain, fever, nausea, and loss of appetite. Stool may contain mucus or blood.
In its most dangerous form, pseudomembranous colitis can lead to severe dehydration, a dangerously swollen colon (toxic megacolon), perforation of the colon wall, kidney failure, or sepsis. A rapidly distending abdomen, high fever, and a sudden decrease in diarrhea (which can paradoxically signal worsening because the colon has stopped functioning normally) are warning signs of a life-threatening complication.
How It Is Diagnosed
Diagnosis usually starts with a stool test. The most common approach uses a nucleic acid amplification test (NAAT), which detects the genetic material of C. diff toxins. This test is about 95% sensitive, meaning it catches the vast majority of true infections. An older method, the enzyme immunoassay, only catches 53 to 60% of cases but is cheaper and faster. Many hospitals now use a two-step approach, screening with one test and confirming with the other, to improve accuracy. Both methods have specificity above 90%, so false positives are uncommon.
If the diagnosis is uncertain or the case is severe, a doctor may perform a sigmoidoscopy or colonoscopy. The raised yellow-white plaques on the colon lining are distinctive and can confirm pseudomembranous colitis visually even when stool tests are inconclusive.
Treatment
The first step is stopping the antibiotic that triggered the infection, whenever that is medically possible. From there, treatment focuses on killing the C. diff bacteria directly.
Current guidelines from the Infectious Diseases Society of America favor fidaxomicin as the preferred first-line treatment for an initial episode. It is taken twice daily for 10 days and is associated with lower recurrence rates compared to alternatives. Vancomycin taken by mouth four times daily for 10 days remains an acceptable option, particularly when cost is a concern, since fidaxomicin is significantly more expensive.
Staying hydrated is critical during treatment, especially when diarrhea is frequent. Most people begin to improve within a few days of starting the right antibiotic, though full recovery can take one to two weeks.
Recurrence and Fecal Transplant
One of the most frustrating aspects of C. diff infection is its tendency to come back. Roughly 1 in 5 people who recover will experience a recurrence, often within weeks of finishing treatment. Each recurrence increases the odds of yet another episode.
For people who experience two or more recurrences despite antibiotic treatment, fecal microbiota transplantation (FMT) becomes an option. This procedure introduces stool from a healthy donor into the patient’s colon, essentially repopulating it with a diverse, balanced bacterial community that can suppress C. diff. FMT has shown high success rates for persistent infections and is now a well-established treatment for recurrent cases.
Prevention in Hospitals and Care Facilities
C. diff spreads through spores that are remarkably tough. They survive on surfaces for months and resist standard alcohol-based hand sanitizers. The CDC recommends several layers of prevention in healthcare settings:
- Contact precautions: patients with suspected or confirmed C. diff are placed in a private room with a dedicated toilet, and healthcare workers wear gloves and gowns
- Handwashing with soap and water: physically scrubbing hands is necessary because alcohol gels do not kill C. diff spores
- Sporicidal cleaning agents: patient rooms must be cleaned daily with EPA-registered products specifically rated to kill C. diff spores, and terminal cleaning with the same agents is required after discharge
- Extended precautions: contact precautions should continue for at least 48 hours after diarrhea resolves, and sometimes for the entire hospital stay
For individuals, the most effective prevention is avoiding unnecessary antibiotics. When antibiotics are genuinely needed, using the narrowest-spectrum option for the shortest effective duration minimizes disruption to gut bacteria and reduces the window for C. diff to take hold.